ARTV vs VRTX: Which Stock is Better?

Side-by-side comparison of Artiva Biotherapeutics Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

ARTV

Artiva Biotherapeutics Inc

$10.80

VRTX

Vertex Pharmaceuticals Inc

$423.92

Key Metrics Comparison

MetricARTVVRTXWinner
Market Cap$253.10M$108.71BVRTX
P/E RatioN/A27.93VRTX
EPS (TTM)$N/A$15.30VRTX
Revenue Growth-1.0%0.1%VRTX
Gross Margin0.0%53.7%VRTX

Analyze ARTV

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ARTV or VRTX a better investment?

Comparing ARTV and VRTX: Artiva Biotherapeutics Inc has a market cap of $253.10M while Vertex Pharmaceuticals Inc has $108.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ARTV and VRTX?

ARTV (Artiva Biotherapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ARTV or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ARTV or VRTX?

VRTX has higher revenue growth at 0.1% vs -1.0% for ARTV.

Which company is more profitable: ARTV or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for ARTV.

Which is the larger company: ARTV or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $108.71B compared to $253.10M for ARTV.

Should I buy ARTV or VRTX in 2026?

Both ARTV and VRTX have investment merit. ARTV trades at $10.80 while VRTX trades at $423.92. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ARTV and VRTX stock?

Key differences: Market Cap ($253.10M vs $108.71B), P/E Ratio (N/A vs 27.9x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).

Popular Stock Comparisons